Jincong Zhuo,Meizhong Xu,Chunhong He,Colin Zhang,Ding-Quan Qian,David M. Burns,Yun-Long Li,Brian Metcalf,Wenqing Yao
申请号：
US15925996
公开号：
US20180282340A1
申请日:
2018.03.20
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
